Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeonghun Han

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
ACS Applied Materials & Interfaces|December 16, 2025
Self-Pumping Spheroid Membrane Enabling Long-Term Spheroid Culture and Label-Free Immune Cytotoxicity ScreeningHyunji Jo, Jaehyung Jeon, Gwang Myeong Seo, et al.
Journal of Oncology|July 6, 2019
Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone DeacetylaseJeonghun Han, Wanyoung Lim, Daeun You, et al.
RSC Advances|April 15, 2022
Manipulation of light transmission from stable magnetic microrods formed by the alignment of magnetic nanoparticlesYoon Ji Seo, Hyung Gyu Lee, Jun Seok Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 18, 2016
Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expressionSangmin Kim, Jeonghun Han, Myeongjin Jeon, et al.
Oncology Reports|January 29, 2013
Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cellsSoo-Jin Oh, Seung Pil Jung, Jeonghun Han, et al.
Oncology Reports|September 2, 2014
Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cellsSangmin Kim, Myeongjin Jeon, Jeongmin Lee, et al.
Anticancer Research|November 24, 2011
Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cellsSangmin Kim, Jeonghun Han, Jee Soo Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecologyJeonghun Han, Yukyung Jun, So Hyun Kim, et al.
Journal of Tissue Engineering and Regenerative Medicine|November 8, 2022
Effective decellularization of human skin tissue for regenerative medicine by supercritical carbon dioxide techniqueNguyen Ngan Giang, Xuan-Tung Trinh, Jeonghun Han, et al.
The Analyst|July 25, 2024
Efficient separation of large particles and giant cancer cells using an isosceles trapezoidal spiral microchannelChanyong Park, Wanyoung Lim, Ryungeun Song, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
ACS Applied Materials & Interfaces|December 16, 2025
Self-Pumping Spheroid Membrane Enabling Long-Term Spheroid Culture and Label-Free Immune Cytotoxicity ScreeningHyunji Jo, Jaehyung Jeon, Gwang Myeong Seo, et al.
Journal of Oncology|July 6, 2019
Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone DeacetylaseJeonghun Han, Wanyoung Lim, Daeun You, et al.
RSC Advances|April 15, 2022
Manipulation of light transmission from stable magnetic microrods formed by the alignment of magnetic nanoparticlesYoon Ji Seo, Hyung Gyu Lee, Jun Seok Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 18, 2016
Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expressionSangmin Kim, Jeonghun Han, Myeongjin Jeon, et al.
Oncology Reports|January 29, 2013
Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cellsSoo-Jin Oh, Seung Pil Jung, Jeonghun Han, et al.
Oncology Reports|September 2, 2014
Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cellsSangmin Kim, Myeongjin Jeon, Jeongmin Lee, et al.
Anticancer Research|November 24, 2011
Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cellsSangmin Kim, Jeonghun Han, Jee Soo Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecologyJeonghun Han, Yukyung Jun, So Hyun Kim, et al.
Journal of Tissue Engineering and Regenerative Medicine|November 8, 2022
Effective decellularization of human skin tissue for regenerative medicine by supercritical carbon dioxide techniqueNguyen Ngan Giang, Xuan-Tung Trinh, Jeonghun Han, et al.
The Analyst|July 25, 2024
Efficient separation of large particles and giant cancer cells using an isosceles trapezoidal spiral microchannelChanyong Park, Wanyoung Lim, Ryungeun Song, et al.
Pageof 3